ZLAB Stock Analysis: Buy, Sell, or Hold?
ZLAB - Zai Lab Limited American Depositary Shares
$26.01
-0.01 (-0.04%)
▼
5d:
+0.42%
30d:
+32.16%
90d:
+36.18%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 06, 2026
0d
Get Alerted When ZLAB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: ZLAB shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: ZLAB shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: ZLAB is currently trading at $26.01, which is considered extended relative to its 30-day fair value range of $18.45 to $24.51.
Technical Outlook: Technically, ZLAB is showing sideways momentum. Immediate support is located at $22.50, while resistance sits at $27.50.
Market Sentiment: ZLAB scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $32.39 (+24.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ZLAB is showing sideways momentum. Immediate support is located at $22.50, while resistance sits at $27.50.
Market Sentiment: ZLAB scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $32.39 (+24.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$18.45 -
$24.51
Company Quality Score
33/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
21.1%
All Signals
- BEARISH: Price extended above range (+6.1% above its trading range)
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 24.5% below Wall St target ($32.39)
- WARNING: Composite score 33/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$18.45 -
$24.51
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$22.51
Resistance Level
$27.50
Current Trend
Sideways
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-12.62
Wall Street Target
$32.39
(+24.5%)
Revenue Growth (YoY)
-3.3%
Profit Margin
-41.9%
Share & Embed Analysis
Last updated: August 22, 2026 5:31 PM ET
Data refreshes hourly during market hours. Next update: 6:31 PM
Data refreshes hourly during market hours. Next update: 6:31 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ZLAB showing a specific setup today?
Insider Activity (6 Months)
1
Buys
11
Sells
Net
INSIDERS SELLING
Recent Transactions
Rafael Amado
SELL
2739 shares
2026-04-06
Yajing Chen
SELL
853 shares
2026-04-06
Ying Du
SELL
2653 shares
2026-04-06
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$35 | 50 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$125 | 41 HOLD |
|
MIRM
Mirum Pharmaceuticals Inc |
STRONG BUY
10 analysts |
$138 | 66 BUY |
|
RNA
Atrium Therapeutics, Inc… |
STRONG BUY
15 analysts |
$25 | 37 SELL |
|
IRON
Disc Medicine Inc. |
STRONG BUY
11 analysts |
$101 | 50 HOLD |
